You are here

Company Monitoring Page for JNJ

latest headlines for company on cafepharma

J&J outlines exchange offer for Kenvue shares

Medical Marketing and Media

Mon, 07/24/23 - 09:39 pm

Tags:

JNJ, Kenvue, shareholders

Pfizer, Gilead, GSK to Capture Growing Infectious Diseases Market as J&J Pulls Back

BioSpace

Mon, 07/24/23 - 10:26 am

Tags:

infectious diseases, Pfizer, Gilead Sciences, GSK, JNJ

J&J’s 2Q23 Results Show It’s a Force to Be Reckoned with in Medtech

Medical Devices and Diagnostics Industry

Sun, 07/23/23 - 12:40 pm

Tags:

JNJ, Medtech, earnings

J&J flags potential interference between heart pump and TAVR stents in recall

Medtech Dive

Fri, 07/21/23 - 11:56 am

Tags:

JNJ, Abiomed, TAVR, Impella, device recalls, Medtech

J&J Exceeds Q2 Expectations, Oncology and Immunology Top Pharma Drivers

BioSpace

Thu, 07/20/23 - 09:51 pm

Tags:

Janssen’s newly-merged infectious disease and vaccine unit sees significant pipeline cuts

Fierce Biotech

Thu, 07/20/23 - 10:18 am

Tags:

JNJ, Janssen, infectious disease, vaccines, hepatitis, HIV

Abiomed’s Impella System Hit with Another Recall

Medical Devices and Diagnostics Industry

Wed, 07/19/23 - 05:47 pm

Tags:

JNJ, Abiomed, Impella, TAVR, device recalls, Medtech

J&J ordered to pay mesothelioma patient $18.8M in talc case, pledges to appeal

Fierce Pharma

Wed, 07/19/23 - 11:46 am

Tags:

JNJ, legal, mesothelioma

House Judiciary Committee Probes Big Pharma’s Potential Role in COVID-19 Censorship

BioSpace

Wed, 07/19/23 - 10:23 am

Tags:

Pfizer, JNJ, Merck, Big Pharma, COVID-19, US Congress

Johnson & Johnson becomes 4th drugmaker to file suit against IRA's drug price negotiations

Fierce Pharma

Tue, 07/18/23 - 10:07 pm

Tags:

JNJ, drug pricing, Inflation Reduction Act

J&J touts Rybrevant win in newly diagnosed lung cancer, with key Tagrisso head-to-head readout up next

Fierce Pharma

Mon, 07/17/23 - 07:04 pm

Tags:

JNJ, Rybrevant, non-small cell lung cancer, Takeda, Tagrisso

See which pharma brands are the strongest and fastest-growing in 2023

Medical Marketing and Media

Wed, 07/12/23 - 11:12 pm

Tags:

JNJ, Pfizer, CSL, branding

J&J's Ethicon Faces Mega Electrode Recall

Medical Devices and Diagnostics Industry

Wed, 07/12/23 - 09:26 am

Tags:

Medtech, JNJ, Ethicon, electrodes, device recalls, electrosurger

Janssen emerges as 11th-hour financier for Nanobiotix in $2B+ deal

Medical Marketing and Media

Tue, 07/11/23 - 11:27 pm

Tags:

JNJ, Janssen, Nanobiotix, NBTXR3, soft tissue sarcoma, Hensify

J&J Extends Lifeline to Nanobiotix in Potential $1.8B Licensing Deal

BioSpace

Mon, 07/10/23 - 09:36 pm

Tags:

JNJ, Nanobiotix, NBTXR3, radiotherapy, head and neck cancer

Janssen’s trial of plaque psoriasis therapy meets endpoints

Clinical Trials Arena

Wed, 07/5/23 - 10:18 am

Tags:

Janssen, JNJ, clinical trials, JNJ-2113, plaque psoriasis

Former J&J sales rep indicted on charges of defrauding Boston hospital

Medtech Dive

Thu, 06/29/23 - 11:37 am

Tags:

Medtech, fraud, JNJ, DePuy Synthes, legal, Boston

10 clinical trials to watch in the second half of 2023

BioPharma Dive

Wed, 06/28/23 - 11:44 am

‘You not only know us, you love and trust us:’ How J&J spinoff Kenvue is raising its profile

Medical Marketing and Media

Mon, 06/26/23 - 08:37 pm

Tags:

JNJ, spinoffs, Kenvue, consumer health

GE HealthCare partners with J&J to push spine imaging system

Medtech Dive

Thu, 06/22/23 - 11:31 am

Tags:

Medtech, GE Healthcare, JNJ, DePuy Synthes, spine imaging, OEC 3D Imaging System

Pages

last 30 twitter posts